Showing results (131-140 of 224) with videos related to
Sort By:
Pageof 23
Environmental Research|April 11, 2021
Indoor air quality of 5,000 households and its determinants. Part B: Volatile organic compounds and inorganic gaseous pollutants in the Japan Environment and Children's studyChau-Ren Jung, Yukiko Nishihama, Shoji F Nakayama, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 23, 2015
The impact of in-stent neoatherosclerosis on long-term clinical outcomes: an observational study from the Kobe University Hospital optical coherence tomography registryMasaru Kuroda, Hiromasa Otake, Toshiro Shinke, et al.[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|August 15, 2013
[Validity of the "Kaigo-Yobo Check-List" as a frailty index]Shoji Shinkai, Naoki Watanabe, Hiroto Yoshida, et al.Scientific Reports|September 12, 2022
No association between prenatal lead exposure and neurodevelopment during early childhood in the Japan Environment and Children's StudyHirosuke Inoue, Masafumi Sanefuji, Yuri Sonoda, et al.Journal of Cardiopulmonary Rehabilitation and Prevention|November 13, 2012
Differences in hemodynamic parameters and exercise capacity between patients with pulmonary arterial hypertension and chronic heart failureRyo Nishio, Hidekazu Tanaka, Yasunori Tsuboi, et al.[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|August 8, 2014
[A 10-year community intervention for disability prevention and changes in physical, nutritional, psychological and social functions among community-dwelling older adults in Kusatsu, Gunma Prefecture, Japan]Satoshi Seino, Yu Taniguchi, Hiroto Yoshida, et al.Journal of the American Medical Directors Association|January 5, 2017
Gait Performance Trajectories and Incident Disabling Dementia Among Community-Dwelling Older JapaneseYu Taniguchi, Akihiko Kitamura, Satoshi Seino, et al.Pharmaceuticals (Basel, Switzerland)|May 25, 2024
Switching from Beraprost to Selexipag in the Treatment of Pulmonary Arterial Hypertension: Insights from a Phase IV Study of the Japanese Registry (The EXCEL Study: EXChange from bEraprost to seLexipag Study)Yuichi Tamura, Hiraku Kumamaru, Ichizo Tsujino, et al.Respiratory Medicine Case Reports|July 31, 2025
A management of a patient with chronic thromboembolic pulmonary hypertension prior to surgical resection for lung cancerSatoshi Isomatsu, Kenichiro Takeda, Yu Shionoya, et al.Gerodontology|March 7, 2020
Rate of oral frailty and oral hypofunction in rural community-dwelling older Japanese individualsYoshihiro Kugimiya, Yutaka Watanabe, Takayuki Ueda, et al.Pageof 23